Home LiteratureArticle Details
PMID: 11418575 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.

Journal of bacteriology ·Vol. 183 ·No. 14 ·2001-07-00 ·Pages 4330-44

Finck-Barbançon V, Frank DW

Abstract

Expression of ExoU by Pseudomonas aeruginosa is correlated with acute cytotoxicity in a number of epithelial and macrophage cell lines. In vivo, ExoU is responsible for epithelial injury. The absence of a known motif or significant homology with other proteins suggests that ExoU may possess a new mechanism of toxicity. To study the intracellular effects of ExoU, we developed a transient-transfection system in Chinese hamster ovary cells. Transfection with full-length but not truncated forms of ExoU inhibited reporter gene expression. Inhibition of reporter activity after cotransfection with ExoU-encoding constructs was correlated with cellular permeability and death. The toxicity of truncated versions of ExoU could be restored by coexpression of the remainder of the molecule from separate plasmids in trans. This strategy was used to map N- and C-terminal regions of ExoU that are necessary but not sufficient for toxicity. Disruption of a middle region of the protein reduces toxicity. This portion of the molecule is postulated to allow the N- and C-terminal regions to functionally complement one another. In contrast to ExoS and ExoT, native and recombinant ExoU molecules do not oligomerize or form aggregates. The complex domain structure of ExoU suggests that, like other P. aeruginosa-encoded type III effectors (ExoS and ExoT), ExoU toxicity may result from a molecule that possesses more than one activity.

MeSH Terms
Animals Bacterial Proteins/genetics,toxicity Bacterial Toxins/genetics,toxicity Binding Sites CHO Cells Cell Membrane Permeability Cricetinae Cytotoxins/genetics,toxicity Gene Expression Genes, Reporter Green Fluorescent Proteins Luminescent Proteins/genetics Oligopeptides Pseudomonas aeruginosa/genetics Recombinant Fusion Proteins/genetics,toxicity
Chemicals
Bacterial Proteins Bacterial Toxins Cytotoxins Luminescent Proteins Oligopeptides Recombinant Fusion Proteins pseudomonas exoprotein A protein, Pseudomonas aeruginosa Green Fluorescent Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Finck-Barbançon V
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Frank D W
References (42)
42 references, click to expand
  1. Towards deciphering the Helicobacter pylori cytotoxin.
    Mol Microbiol. 1999 Oct;34(2):197-204 PMID: 10564464
  2. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
    Infect Immun. 1999 Oct;67(10):5530-7 PMID: 10496945
  3. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
    Infect Immun. 2000 May;68(5):2916-24 PMID: 10768989
  4. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
    Infect Immun. 2000 Jul;68(7):3998-4004 PMID: 10858214
  5. Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.
    Infect Immun. 1993 Jan;61(1):307-13 PMID: 8418052
  6. The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2320-4 PMID: 8460141
  7. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
    Infect Immun. 1994 Feb;62(2):554-63 PMID: 8300213
  8. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.
    Am J Physiol. 1994 Nov;267(5 Pt 1):L551-6 PMID: 7977765
  9. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
    Infect Immun. 1995 Jan;63(1):1-8 PMID: 7806344
  10. Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism.
    Infect Immun. 1995 Mar;63(3):825-32 PMID: 7868253
  11. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
    Infect Immun. 1995 Apr;63(4):1541-51 PMID: 7890421
  12. Functional domains of Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1995 Aug;63(8):3182-6 PMID: 7622246
  13. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):11998-2002 PMID: 8618831
  14. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.
    Mol Microbiol. 1996 Dec;22(5):991-1003 PMID: 8971719
  15. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.
    Infect Immun. 1997 Feb;65(2):579-86 PMID: 9009316
  16. Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.
    J Virol. 1997 Mar;71(3):1757-65 PMID: 9032304
  17. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury.
    Mol Microbiol. 1997 Jun;24(6):1249-62 PMID: 9218773
  18. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly.
    J Cell Biol. 1997 Aug 25;138(4):759-69 PMID: 9265644
  19. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Mol Microbiol. 1997 Aug;25(3):547-57 PMID: 9302017
  20. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon.
    J Bacteriol. 1997 Nov;179(22):7165-8 PMID: 9371466
  21. The exoenzyme S regulon of Pseudomonas aeruginosa.
    Mol Microbiol. 1997 Nov;26(4):621-9 PMID: 9427393
  22. The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton.
    Mol Microbiol. 1998 Jan;27(2):359-68 PMID: 9484891
  23. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Mol Microbiol. 1998 Feb;27(4):807-18 PMID: 9515706
  24. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites.
    J Biol Chem. 1998 Mar 27;273(13):7332-7 PMID: 9516428
  25. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1998 Jun;66(6):2607-13 PMID: 9596723
  26. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections.
    Infect Immun. 1998 Jul;66(7):3242-9 PMID: 9632591
  27. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets.
    Mol Microbiol. 1998 Sep;29(5):1263-74 PMID: 9767593
  28. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system.
    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13899-904 PMID: 9811898
  29. Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin.
    J Bacteriol. 1998 Dec;180(23):6224-31 PMID: 9829931
  30. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells.
    Infect Immun. 1999 Feb;67(2):708-16 PMID: 9916081
  31. Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
    Infect Immun. 1999 Feb;67(2):914-20 PMID: 9916108
  32. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells.
    Mol Microbiol. 1998 Nov;30(4):751-9 PMID: 10094623
  33. A complex composed of SycN and YscB functions as a specific chaperone for YopN in Yersinia pestis.
    Mol Microbiol. 1998 Nov;30(4):777-88 PMID: 10094626
  34. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.
    Infect Immun. 1999 Apr;67(4):2040-4 PMID: 10085057
  35. Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin.
    J Biol Chem. 1999 Apr 2;274(14):9277-82 PMID: 10092603
  36. Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases.
    J Biol Chem. 1999 Apr 2;274(14):9503-8 PMID: 10092634
  37. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury.
    Nat Med. 1999 Apr;5(4):392-8 PMID: 10202927
  38. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Mol Microbiol. 1999 Apr;32(2):393-401 PMID: 10231494
  39. Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system.
    Infect Immun. 1999 Jun;67(6):3151-4 PMID: 10338535
  40. ADP-ribosylation of oncogenic Ras proteins by pseudomonas aeruginosa exoenzyme S in vivo.
    Mol Microbiol. 1999 Jun;32(5):1054-64 PMID: 10361307
  41. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.
    J Clin Invest. 1999 Sep;104(6):743-50 PMID: 10491409
  42. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    J Biol Chem. 1999 Dec 17;274(51):36369-72 PMID: 10593930
Article Info
Journal
Journal of bacteriology
Abbr.
J Bacteriol
ISSN
0021-9193
Published
2001-07-00
Pages
4330-44
Language
English
Region
United States
NLM ID
2985120R
PMCID
PMC95324
Subset
IM
Grants
NHLBI NIH HHS · HL59239 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]